Dr Dejan Radeski

Dr. Dejan Radeski is a highly skilled consultant haematologist who specialises in the treatment of T-cell lymphoma and post-transplant lymphoproliferative disorders. With an impressive academic background and years of clinical experience, he has become one of the foremost experts in his field.

Dr. Radeski obtained his medical degree from the University of Western Australia, where he received rigorous training in hematology. He then went on to complete his residency in Perth before travelling to the Centre for Lymphoid Malignancies at Columbia University in New York to further his training. There, he honed his skills in the treatment of complex lymphoid malignancies, particularly T-cell lymphomas and post-transplant lymphoproliferative disorders.

In his clinical practice, Dr. Radeski focuses on providing his patients with tailored treatment plans that are based on the latest advancements in hematology research. With a compassionate approach and a deep understanding of the needs of his patients, he has earned a reputation as one of the most skilled and dedicated hematologists in the field.

Dr. Radeski's research interests include the identification of novel treatment strategies for T-cell lymphomas and post-transplant lymphoproliferative disorders. Through his work, he has contributed significantly to our understanding of these difficult-to-treat conditions, and he is committed to advancing the field of hematology through ongoing research and collaboration with his peers. Overall, Dr. Radeski is a leader in the field of hematology, and his contributions to the treatment and management of T-cell lymphoma and post-transplant lymphoproliferative disorders have helped countless patients achieve better outcomes.